Merck (MRK) Assets Average (2009 - 2026)

Merck (MRK) has reported Assets Average for 18 consecutive years, with $129.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets Average rose 11.11% year-over-year to $129.2 billion in Q2 2026; TTM through Jun 2026 was $129.2 billion, a 11.11% increase from a year earlier, with the FY2025 full-year figure at $127.0 billion, up 13.49% from the prior year.
• Assets Average was $129.2 billion for Q2 2026 at Merck, down from $132.8 billion in the prior quarter.
• Over five years, Assets Average peaked at $133.2 billion in Q4 2025 and troughed at $105.6 billion in Q3 2023.
• A 5-year average of $114.1 billion and a median of $108.9 billion in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average rose 17.75% in 2022 and retreated 2.04% in 2024, its largest moves.
• Over 5 years, Assets Average stood at $108.1 billion in 2022, then decreased by 1.31% to $106.7 billion in 2023, then rose by 9.95% to $117.3 billion in 2024, then advanced by 13.54% to $133.2 billion in 2025, then fell by 2.97% to $129.2 billion in 2026.
• The last three Assets Average figures came in at $129.2 billion (Q2 2026), $132.8 billion (Q1 2026), and $133.2 billion (Q4 2025), per Business Quant data.